Author:
Nardini Cecilia,Sprenger Jan
Abstract
Randomized controlled trials are currently the gold standard within evidence-based medicine. Usually they are monitored for early signs of effectiveness or harm. However, evidence from trials stopped early is often charged with bias toward implausibly large effects. To our mind, this skeptical attitude is unfounded and caused by the failure to perform appropriate conditioning in the statistical analysis of the evidence. We contend that conditional hypothesis tests give a superior appreciation of the obtained evidence and significantly improve the practice of sequential medical trials, while staying firmly rooted in frequentist methodology.
Publisher
Cambridge University Press (CUP)
Subject
History and Philosophy of Science,Philosophy,History
Reference26 articles.
1. Food and Drug Administration. 2010. “Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials.” http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm071072.htm.
2. Inference by Eye: Confidence Intervals and How to Read Pictures of Data.
3. Toward Evidence-Based Medical Statistics. 1: The P Value Fallacy
4. Monitoring in clinical trials: benefit or bias?
5. Stopping Randomized Trials Early for Benefit and Estimation of Treatment Effects;Bassler;Journal of the American Medical Association,2010
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献